Families’ trust in consumer-grade pulse oximeters “seemed inappropriately high,” and few families were trained in use of the devices, according to the study authors. A significant percentage of ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today mailed a ...

Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry ...

Stork leverages the same Masimo SET® pulse oximetry technology developed over 35 years ago and is the only device with over-the-counter FDA clearance for use on neonates the day they come home*.

Urges Stockholders to Vote “FOR” Only Masimo’s Director Nominees, Joe Kiani and Christopher Chavez, on the Updated GOLD Proxy Card Masimo Corporation ...

Masimo (NASDAQ: MASI) Signal Extraction Technology ®, or SET ®, pulse oximetry ? industry-leading, clinically proven, and used by top hospitals everywhere ? continues to overcome the limitations ...

Masimo SET® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than ...